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Inert macrocyclic Eu3+ complex with affirmative
paraCEST features†
Tanja Gambino, a Laura Valencia, b Paulo Pérez-Lourido, b
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Goran Angelovski *a
We report on a macrocyclic platform based on an 18-membered macrocycle that forms kinetically highly
inert paramagnetic complexes and possesses an excellent outlook for the development of bioresponsive
paraCEST (paramagnetic chemical exchange saturation transfer) contrast agents. The investigated euro-
pium(III) chelate is non-hydrated and contains four amide groups, each possessing two paramagnetically
shifted proton resonances distant from bulk water. The X-ray crystal structure and solution studies indi-
cate that the metal ion is ten-coordinated, being directly bound to the six N atoms of the macrocycle and
the four amide O atoms of the pendant arms. The complex presents an excellent inertness with respect
to dissociation, being stable under a variety of harsh conditions, including highly acidic and basic media or
elevated temperatures. The amide protons are in slow-to-intermediate exchange with bulk water, which
gives rise to the generation of a strong CEST effect at low probe concentration and saturation powers
(∼25% at 5 mM, B1 = 5 μT, 37 °C). We demonstrate the potential of this platform for mapping pH in its
microenvironment and foresee potential for the development of diverse paraCEST probes and sensors.
Introduction
Efficient detection and monitoring of pathological processes is
a key step in ensuring the timely diagnosis of numerous dis-
eases. Various molecular imaging techniques aim for develop-
ing reliable protocols to visualize such biological events, with
magnetic resonance imaging (MRI) being at the forefront of
this progress. In addition to the ability to cover larger volumes
or enable investigations of tissues at any depth, MRI possesses
outstanding potential and versatility to study functional pro-
cesses with an unprecedented specificity and spatial
resolution.1,2 This was initially recognized slightly over two
decades ago with the first reports on the ‘smart’ contrast
agents;3,4 meanwhile different nuclei, MRI protocols or biore-
sponsive probes have been employed in attempts to assess the
functional state of tissues,5,6 especially the environmental pH
as one of the best physiological markers of different diseases,
including inflammation,7 infection,8 ischemia9 and cancer.10
Chemical exchange saturation transfer (CEST) is an emer-
ging MRI methodology appreciated due to a few advantageous
features that circumvent the current shortcomings of other
existing methods.11 CEST takes advantage of the magnetiza-
tion transfer between the exchanging species operating at two
different frequencies (most frequently a pool of protons from
the CEST probe and bulk water), thus reducing the magnetiza-
tion of the latter once the former species is irradiated with a
radiofrequency (RF) pulse of defined energy. The great advan-
tage of this strategy is the ability of providing signal response
at will: the CEST effect or image will be generated only with
the application of desired saturation pulses. Moreover, the
existence of at least two separate exchange processes (e.g. two
separate pools of protons in exchange with protons from bulk
water) paves the way for highly specific, multifrequency and
consequently multicolour CEST measurements. It also favours
ratiometric approaches, i.e. exploitation of these separate
exchange processes for providing information on the influence
of an ion or a molecule in the probe microenvironment, but
independent on probe concentration.12 Finally, since the
exchange rates are intrinsically tied to the resulting intensity
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of CEST, any alteration on the exchange rates will ultimately
modulate the recorded CEST effect. For instance, pH changes
in the microenvironment of the CEST pair(s) affect the satur-
ation transfer process and thus the CEST MR image.
Several useful approaches have been reported in attempts
to develop CEST probes and methods enabling pH mapping in
tissue,13–21 or for development of bioresponsive agents that
can help observing various biological processes.22–25 For
instance, a recent report demonstrated the use of ratiometric
CEST MRI to map renal pH using a diaCEST agent in vivo.26
Irrespective if they are comprised of diamagnetic molecules
or those with paramagnetically shifted protons (dia- or
paraCEST probes, respectively), their common feature is the
presence of the CEST-active pool sufficiently distant from bulk
water frequency. This ensures effective magnetization transfer
(MT) and adjustment of the exchange rates in the slow
exchange regime, thus allowing low energy saturation pulses to
produce detectable CEST effects. In fact, this is a critical
aspect for the use of any CEST-based probe in vivo: due to the
specific absorption rate (SAR) limitations, i.e. the energy depo-
sition in tissue, it is essential to use low energy saturation
pulses (low B1 fields).
27,28 Despite an advantageous feature of
the currently available paraCEST agents to shift the CEST fre-
quency sufficiently away from the semi-solid MT (tissue back-
ground CEST), most of them still lack the optimal exchange
regimes to provide the most efficient labelling efficiency (α)
and hence to be used at reduced probe concentrations at low
B1 fields. These limitations of the currently available probes
are certainly the main obstacle for the translation of CEST
agents to clinical practice, in spite of the intense research
efforts in this field during the last two decades.29–31
Taking these demands into consideration, we developed a
paramagnetic platform that encompasses the majority of the
parameters necessary for a prospective paraCEST probe. We
built upon the previous work on the 18-membered macrocyclic
molecule that provides exceptionally inert Pr3+, Eu3+ or Yb3+
complexes and exhibits the paraCEST effect.32 We improved
the previous system by incorporating amide instead of
hydroxyl groups (Fig. 1), thus obtaining 8 instead of 4 exchan-
ging protons. Furthermore, being geometrically oriented in a
different manner, we anticipated their grouping into two pairs
of protons. This opens the possibility of getting two CEST
effects at two different frequencies. An additional favourable
property of this 18-membered macrocycle platform is the for-
mation of Ln3+ complexes that lack coordinated water
molecules.32–35 The presence of coordinated water molecules
in exchange with bulk water shortens the longitudinal relax-
ation times of the bulk water signal, which is detrimental to
the CEST effect.36 Concurrently, this feature increases the
number of coordination bonds between the multidentate che-
lator and the metal ion, thus significantly improving inertness
of the obtained chelate.
Experimental section
General remarks
1H NMR spectra of the ligand and complexes were recorded on a
Bruker ARX400 spectrometer, while the CEST experiments were
performed on a Bruker Avance III NMR spectrometer (Bruker,
Ettlingen, Germany). Chemical shifts were referenced by using
the residual solvent proton signals.37 Elemental analysis was per-
formed in a Carlo-Erba EA 1108 microanalyzer. Attenuated total
reflection Fourier transform infrared spectroscopy (ATR-FTIR)
spectra were recorded as KBr discs on a Bruker VECTOR 22
spectrometer. ESI experiments were performed on an microTOF
(focus) mass spectrometer (Bruker Daltonics, Bremen, Germany)
or an ion trap SL 1100 system from Agilent (Germany). For the
former, the ions were generated using an ApolloII (ESI) source
and ionization was achieved by electrospray.
UV-Vis absorption spectra were recorded on a Jasco V-650
spectrometer using 1 cm quartz cells. The excitation and emis-
sion spectra in the UV-Vis region were obtained with a Horiba
FluoroMax Plus-P spectrofluorometer equipped with a 150 W
ozone-free xenon arc lamp and a R928P photon counting emis-
sion detector. All spectra were corrected for the instrumental
response provided by the manufacturer. An integration time
of 0.1 s was used in all steady state measurements.
Luminescence decays were measured on the same instrument
working in the phosphorescence mode using a xenon flash
lamp. Emission lifetimes were obtained by least-squares fits of
the decay data using monoexponential decay functions. The
emission quantum yield of EuL was obtained with optically
diluted solutions using the trisdipicolinate complex Cs3[Eu




caphane-3,6,10,13-tetrayl)tetraacetamide (L). The macrocyclic
precursor 3,6,10,13-tetraaza-1,8(2,6)-dipyridinecyclotetradeca-
phane40 (1.50 g, 4.60 mmol) and Na2CO3 (2.968 g, 28 mmol)
were refluxed in acetonitrile (50 mL). A solution of 2-bromo-
acetamide (3.379 g, 24 mmol) in acetonitrile (30 mL) was
added dropwise to the reaction mixture, which was refluxed for
24 hours. The mixture was allowed to cool and the solid
obtained was isolatred by filtration, washed with water and
recrystallized from methanol to give a white crystalline solid,
which was collected by filtration and dried providing 1.240 g of
Fig. 1 Chemical structure of the complex studied in this work. NMR-equi-
valent protons on amides were deliberately marked with same colour.
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L·H2O (yield 51%). C26H40N10O5 (572.32): calcd C 54.5, H 7.0, N
24.5; found C 54.2, H 7.3, N 24.7. IR (ATR, cm−1): 1594 (s), 1456
(s) [ν(CvC) and ν(CvN)py], 1676 (s) [ν(CvO)], 3165 (m)
[ν(NH)]. MS (ESI-MS, m/z, found (calculated)): 555.3 (555.3) [L +
H]+. 1H NMR (CD3OD, δ, ppm): H1 7.70 (t, 2H), H2 7.25 (d, 4H,
3J = 7.7 Hz), H4 3.37 (b, 8H), H5 2.75 (b, 8H), H6 3.14 (b, 8H).
General procedure for the preparation of the complexes
A solution of Ln(NO3)3·xH2O (0.04 mmol) in methanol (5 mL)
was added to a stirred solution of L·H2O (0.023 g, 0.04 mmol)
in the same solvent (10 mL) and the mixture was slightly
heated. Slow concentration of the methanolic solutions gave
crystalline products that were isolated by filtration and dried.
[EuL](NO3)3·3H2O. The complex was prepared using L·H2O
(0.023 g, 0.04 mmol) and Eu(NO3)3·5H2O (0.017 g, 0.04 mmol).
Yield: 0.022 g, 60%. Anal. Calcd for C26H44N13O16Eu: C, 33.0;
H, 4.7; N, 19.2%. Found: C, 33.1; H, 4.9; N, 19.1%. ESI-MS
(m/z, found (calculated)): 705.3 (705.2) [Eu(L–2H)]+. IR (ATR-FTIR):
1592 (s), 1454 (s) [ν(CvC) and ν(CvN)py], 1651 (s) [ν(CvO)],
3262 (m), 3162 (m) ν(NH2), 1314 (s), 829 (m) [ν(NO3
−)] cm−1.
Crystals suitable for X-ray diffraction were obtained by slow
evaporation of an aqueous solution of the complex.
[YL](NO3)3·3H2O. The complex was prepared using L·H2O
(0.023 g, 0.04 mmol) and Y(NO3)3·6H2O (0.015 g, 0.04 mmol).
Yield: 0.028 g, 79%. Anal. Calcd for C26H44N13O16Y: C, 35.3; H,
5.0; N, 20.6%. Found: C, 35.7; H, 5.5; N, 20.3%. ESI-MS (m/z,
found (calculated)): 704.2 (704.2) [Y(L–H)(NO3)]
+; 641.2 (641.2)
[Y(L–2H)]+. IR (ATR-FTIR): 1604 (s), 1459 (s) [ν(CvC) and
ν(CvN)py], 1661 (s) [ν(CvO)], 3169 (m) ν(NH2), 1321 (s),
888 (m), 747 (m) [ν(NO3
−)] cm−1. Crystals with formula
[YL](NO3)3·3H2O suitable for X-ray diffraction were obtained by
slow evaporation of an aqueous solution of the complex.
Crystal structure determinations
Crystallographic data of [EuL](NO3)3·3H2O were collected at 293(2)
K on a BRUKER Smart-CCD-1000 diffractometer using Graphite
monochromated Mo-Kα radiation. All data were corrected by
Lorentz and polarization effects. For [YL](NO3)3·3H2O, crystallo-
graphic data were measured at room temperature using a Bruker
Smart 6000 CCD detector and Cu-Kα radiation (λ = 1.54178 Å) gen-
erated by an Incoatec microfocus source equipped with Incoatec
Quazar MX optics. The software APEX2 was used for collecting
frames of data, indexing reflections, and the determination of
lattice parameters, while SAINT was used for integration of the
intensity of reflections.41 The software SADABS was used in all
cases for scaling and empirical absorption correction.42 All struc-
tures were solved by using the SHELXT program and refined by a
full-matrix least-squares based on F2.43 The Squeeze program was
used to correct the reflection data for the diffuse scattering due to
the disordered nitrate ions and water molecules present in the
unit cell of [EuL](NO3)3·3H2O.
44 Non-hydrogen atoms were refined
with anisotropic displacement parameters. Hydrogen atoms were
included in idealized positions and refined with isotropic displa-
cement parameters. CCDC 1886847 and 1886848† contain the
supplementary crystallographic data for this paper. Molecular
graphics were generated using ORTEP-3.45
CEST experiments and the optimal kex
CEST experiments. The saturation transfer experiments
were carried out at 25 or 37 °C by irradiating the EuL sample
at increments of 0.5 ppm in the frequency range ±20 ppm,
then at increments of 1 ppm in the frequency range
−50 to −20 and +20 to +50 ppm followed by an FID readout;
for iopamidol, we irradiated the sample at increments of
0.25 ppm in the frequency range ±10 ppm, then at increments
of 5 ppm in the frequency range −50 to −10 and +10 to
+50 ppm. Spectra were measured by recording the bulk water
signal intensity as a function of the presaturation frequency.
Saturation offsets are reported relative to the resonance fre-
quency of bulk water.
For each temperature, data were collected by varying the sat-
uration power whilst the saturation time remained constant (5
s for experiments reported in Fig. 4, or 15 s for the experi-
ments reported in Fig. 5, ESI Fig. S8–11† and Table 1). The sat-
uration field strengths used were: 2.5, 3, 5, 6, 7.5, 10 and 15 μT
for experiments reported in the Fig. 4, or 1, 2.5, 5, 7.5, 10, 12.5
and 15 μT for the experiments reported in Fig. 5, S8–11† and
Table 1. Longitudinal relaxation times were obtained in an
independent experiment using the standard inversion-recovery
method with 1% gradient to eliminate the radiation damping
effect. The CEST experiments at variable pH (experiments
reported in Fig. 5, ESI Fig. S8–11† and Table 1) were performed
using a 5 mm NMR tube with EuL dissolved in a 9 : 1 mixture
H2O : D2O (v/v). The CEST experiments with shorter saturation
(5 s) were performed using a 5 mm NMR tube filled with an
aqueous solution of EuL or iopamidol and a smaller 2 mm
NMR tube (1.6 mm inner diameter) filled with D2O. For data
evaluation, Z-spectra were normalized by an unsaturated fully
relaxed water signal M0. The CEST effect was calculated
employing the inverse asymmetry analysis of the normalized
Z-magnetization. The inverse difference of the magnetization
transfer, MTRind, was calculated according to eqn (1), where
M0 is the unsaturated water magnetization, while Mz+ and Mz−
are magnetizations of the on-resonance at the frequency +Δω
and of the off-resonance at the frequency −Δω relative to bulk
water, respectively.46




Simultaneous multi-B1 Z-spectra fitting was performed as
described previously,47 using the tool published online.48
Table 1 Exchange rates (in Hz) determined with the qCEST method for
EuL (5 mM) at variable pH (PBS, 37 °C).47
pH Peak at 8 ppm Peak at 14 ppm
6.0 138 ± 19 66 ± 23
6.4 321 ± 30 162 ± 31
6.8 941 ± 75 487 ± 69
7.2 2631 ± 130 1364 ± 101
7.6 5631 ± 225 2977 ± 150
8.0 15 481 ± 1792 7368 ± 1002
Research Article Inorganic Chemistry Frontiers

























































































Optimal kex. For a radiofrequency (RF) saturation pulse, the
SAR grows quadratically with its amplitude; thus, if approach-
ing to a steady state is desired, B1 fields of max. 15 µT (ω1 =
2π·600 Hz) could be applied without making a lethal harm to
an animal.20,21,31 However, even lower amplitudes are
suggested to reduce the stress for the animal and tissue
temperature.27,28 Naturally, if talking about human experi-
ments, even lower SAR values are allowed or are possible, on
the level of up to 6 µT.
Theoretically, the CEST effect that can be acquired with a B1
of 10 µT (2π·400 Hz ≅ 2700 Hz) directly depends on the
exchange rate by the labeling efficiency relation (eqn (2)):
α ¼ γ
2B12
γ2B12 þ k2 ð2Þ
It is also well known and easy to calculate that this function
has a maximum of 0.5 for k = γ × B1. Thus for the limit of B1 =
10 µT, the optimal CEST effect can be achieved with a CEST
exchange rate of k = γ × 10 µT = 2700 Hz.
CEST simulations. Simulated Z-spectra and MTRasym effects
were obtained at B0 = 7 T using the computational method
based on the Bloch–McConnell equations,47 and recently used
for multi-pool CEST simulations including the in vivo-like semi-
solid MT pool.49 Two separate sets of calculations were per-
formed, assuming conditions suitable for clinical (B1 = 5 μT, sat-
uration time = 0.5 s) or preclinical (B1 = 10 μT, saturation time =
5 s) settings. For the results reported in Fig. 6, the fractional con-
centration, χ, was calculated for 10 mM concentration of exchang-
ing protons using the following equation χ = 10 × 10−3 M/111
M = 0.00009; however, for results reported in Fig. 7, the fractional
concentration for 5 mM complexes (χ = 0.000045) was taken as
the basis, and then multiplied by the number of exchangeable
protons available in each complex (see ESI Table S4†).
For mimicking a grey brain matter environment of the
paraCEST agents, the water and semisolid MT pool were added
to the CEST simulation using a water longitudinal relaxation
time T1w = 1.67 s, and a transverse relaxation time T2w =
0.043 s. The semisolid MT pool (Super-Lorentzian lineshape)
was defined by its fractional concentration χMT = 0.05, trans-
verse relaxation time T2MT = 9.1 µs, exchange rate kex(MT) =
40 Hz; the chemical shift was set to δMT = 0 ppm for simpli-
city.49 The reported CEST effects were obtained by subtracting
the simulated Z-spectrum that assumed the water, MT and one
or two paraCEST pools with the simulated Z-spectrum that
assumed the water and MT pools only.
MRI experiments
MRI measurements on tube phantoms were performed on a
Bruker BioSpec 70/30 USR magnet (software version Paravision
5.1) using a Bruker volume coil (RF RES 300 1H 075/040 QSN
TR). The MRI phantom consisted of 6 vials filled with a EuL
solution in PBS (3 mM) and the pH ranging from 6.0 to 8.0.
Z-spectra were acquired at room temperature (∼22 °C) with
139 irradiation offsets ranging from 20 to −20 ppm, saturation
pulse duration of 5 s, and five different radiofrequency field
strengths, B1 = 3, 4, 5, 6 and 7.5 µT.
Presaturated MR images were acquired using the rapid
acquisition with relaxation enhancement (RARE) imaging pro-
tocol with the following parameters: repetition time (TR)/echo
time (TE) = 15 316.18/3.26 ms, field of view (FOV) = 48 ×
48 mm, matrix size (MTX) = 96 × 96, slice thickness 2 mm,
rare factor = 96, number of excitation (NEX) = 1, acquisition
time (TA) = 35 min 28 s 948 ms.
Image analysis was performed in MATLAB (MathWorks,
USA). Z-spectrum images were interpolated by splines and
shifted to the centre frequency in order to remove B0 inhom-
ogeneity artefacts.
pH evaluation using the ratiometric method was done
using the inverse matrix approach, as described above in eqn
(1). For generating pH maps, the pH values were plotted as a
function of the corresponding MTRind ratio values. The
obtained values were fitted using an exponential function
according to eqn (3), yielding a monotonic function pH
(MTRind ratio). This function was then applied pixel-wise to
MTRind ratio maps to generate the pH maps.
pH ¼ c a ebMTRind ratio ð3Þ
Results and discussion
Preparation
The synthesis of L started by the preparation of the 3,6,10,13-
tetraaza-1,8(2,6)-dipyridinecyclotetradecaphane precursor by
condensation of diformylpyridine and ethylenediamine using
Ba2+ as a template, and subsequent reduction of the Schiff-
base intermediate with NaBH4 (59% yield).
40,50 Alkylation of
the macrocycle with bromoacetamide in acetonitrile using
Na2CO3 as a base provided L in 51% yield. The paramagnetic
Eu3+ complex was obtained in good yield (60%) by direct reac-
tion of the ligand with the appropriate hydrated lanthanide
nitrate in methanol. The mass spectrum (ESI+) shows intense
peaks due to the [Eu(L–2H)]+ entity that confirm the formation
of the complex (ESI Fig. S1†).
X-ray crystallography
Crystals of formula [EuL](NO3)3·3H2O were obtained by slow
evaporation of aqueous solutions of the complex. They contain
the [EuL]3+ cations, highly disordered nitrate anions and water
molecules. While the quality of the crystallographic data of the
Eu3+ complex is not very high, the overall structure of the
[EuL]3+ complex and the bond distances and angles of the
metal coordination environment are reasonably accurate
(Fig. 2 and ESI Tables S1 and 2†). Furthermore, we obtained
single crystals of the Y3+ analogue (ESI Fig. S2 and ESI Tables
S1 and 2†), which assumes a very similar structure.
The [EuL]3+ cations present ten-coordinate metal ions that
are directly bonded to the six donor atoms of the macrocyclic
skeleton and the four oxygen atoms of the acetamide pendants
(Fig. 2). While ten coordination is relatively uncommon for
lanthanide complexes in aqueous solution, similar ten-co-
ordinated structures were observed previously for complexes
Inorganic Chemistry Frontiers Research Article

























































































based on the same macrocyclic platform functionalized with
acetate,33 methynenepyridine34 or hydroxyethyl32,35 pendant
arms. The ligand L adopts a twist-wrap conformation in which
the angles involving the two pyridyl nitrogen atoms and the
metal ion are nearly linear (>179°). The two pyridyl units are
twisted with respect to each other, so that the least-squares
planes intersect at angles of ca. 19–20°. The coordination poly-
hedron can be best described as a sphenocorona, as confirmed
by performing shape measures with the SHAPE program.51,52
A sphenocorona is a 1 : 5 : 4 polyhedron (Fig. 2) relatively
common in the chemistry of the lanthanide ions.53,54 In the
present case the least-squares containing 5 and 4 donor atoms
present rather large mean deviations from planarity (0.27 and
0.21 Å, respectively, Fig. 2).
Kinetic inertness
The 1H NMR spectrum of EuL recorded in a H2O solution pre-
sents 10 paramagnetically shifted signals in the range ∼20 to
−20 ppm, which is in line with the D2 symmetry observed in
the solid state. The spectrum recorded in 1 M HCl remains
unchanged over a period of at least 25 days (ESI Fig. S3†), with
no signals due to the free ligand being observed. This experi-
ment evidences that the complex presents an astonishing
inertness under very harsh conditions. For instance, the com-
mercially available contrast agent [Gd(DOTA)]− (DOTA –
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate) dis-
sociates with a half-live of ∼30 hours under these conditions.55
The chemical shifts of the paramagnetically shifted signals
could be easily assigned by comparison with those of the ana-
logue bearing hydroxyethyl pendant arms instead of aceta-
mides.35 The similarity of the 1H NMR spectra of these two
complexes indicates that they present similar magnetic aniso-
tropies, and thus similar coordination environments in solu-
tion (ESI Table S3†).
Additional experiments were carried out to assess the inert-
ness of EuL in phosphate buffer at pH 7.0 upon addition of
one equivalent of Zn2+. These conditions were proposed to
study the stability of Gd-based contrast agents.56 The 1H NMR
spectra of EuL (5 mM, 25 °C) recorded in phosphate buffer
(67 mM) before and after addition of one equivalent of Zn2+
are identical, and confirm the stability of the complex under
these conditions. The spectra did not show signals due to dia-
magnetic species and the solution did not show visible pres-
ence of precipitate due to insoluble EuPO4. Moreover, the
1H
NMR spectrum remained unchanged upon incubation of the
mixture at 40 °C for 72 h. 1H NMR experiments were also
recorded at variable temperatures of up to 73 °C (ESI Fig. S4†).
Again no dissociation of the complex was observed, nor signs
of fluxional behaviour, which shows that the complex presents
a very rigid structure in solution. The only noticeable change
observed upon increasing temperature is the decrease of the
observed paramagnetic shifts, as expected due to the 1/T and
1/T2 dependencies of the contact and pseudocontact contri-
butions, respectively.57 The 1H NMR spectrum also remains
unchanged upon increasing the pH to 10.0 (ESI Fig. S5†).
Finally, the EuL complex was challenged with 10 equivalent of
the DTPA chelator (DTPA – diethylenetriamine pentaacetic
acid) in phosphate buffer at pH 7.0. The luminescence steady-
state emission spectrum of the solution did not experience any
noticeable changes upon addition of DTPA over a period of
72 h (ESI Fig. S6†). Furthermore, the luminescence emission
decay curves recorded before and after addition of DTPA are
virtually superimposable, demonstrating that the EuL complex
remains intact under these conditions (ESI Fig. S7†). These
experiments confirm the astonishing kinetic inertness of the
complex, which appears to be related to the efficient protection
from the environment of the metal ion in the ten-coordinate
structure.
UV/Vis and luminescence properties
The UV absorption and luminescence emission experiments
on the EuL complex gave further insights on its coordination
and photophysical properties in solution (Fig. 3). The absorp-
tion spectrum presents a maximum at 268 nm (ε = 11 000 M−1
cm−1) characteristic of the pyridyl group,58 and this band
can be used to sensitized Eu3+ luminescence emission. The
absorption and excitation spectra are almost identical, which
indicates that Eu3+ sensitization occurs via energy transfer
Fig. 2 Top: View of the structure of the [EuL]3+ cation present in crys-
tals of [EuL](NO3)3·3H2O (0.80 Å resolution). Hydrogen atoms (except
those of amide groups) are omitted for simplicity. Bond distances [Å]:
Eu–N(1), 2.593(15); Eu–N(2), 2.63(2); Eu–N(3), 2.644(19); Eu–O(1), 2.525
(16); Eu–O(2), 2.511(15). Bottom: View of the coordination polyhedron
around the metal ion.
Research Article Inorganic Chemistry Frontiers

























































































from excited states of the ligand to Eu3+ excited states. The
luminescence emission spectrum consists of the 5D0 →
7FJ
bands typical for Eu3+. The integrated and corrected relative
intensities of the 5D0 →
7FJ transitions represent 0.21, 15.8,
25.7, 5.5, 39.5, 2.5 and 10.8% of the overall emission intensity
for J = 0, 1, 2, 3, 4, 5 and 6, respectively. Thus, the overall emis-
sion intensity is dominated by the 5D0 →
7F4 transition, while





Furthermore, the 5D0 →
7F0 transition is very weak and the
5D0 →
7F1 transition displays only two of the maximum 2J + 1
components. This emission pattern is characteristic of a rather
symmetric crystal field around the metal coordination environ-
ment,59 which is attributed to the D2 symmetry observed both
in the solid state and in solution. The emission spectrum exhi-
bits unusually intense ΔJ = 5 and ΔJ = 6 transitions, a rare
feature that is characteristic of this type of coordination.34
Further investigations indicated that the excited 5D0 state pre-
sents a monoexponential decay with a lifetime of 0.914 ms
and a modest luminescence quantum yield of ΦEu = 0.11,
which can be attributed to the presence of amide NH oscil-
lators and possibly water molecules in the second-hydration
sphere that provide a rather efficient vibrational deactivation
of the 5D0 excited state of Eu
3+.60 The emission lifetime deter-
mined in D2O solution amounts to 1.902 ms, which results in
a hydration number of q = 0 by using the method proposed by
Beeby including the correction associated to the presence of
four amide NH oscillators.60
CEST experiments
paraCEST properties. The favourable kinetic inertness and
the coordination properties of this non-hydrated paramagnetic
complex indicated its prospected outlook for potential CEST
applications. Especially the lack of coordinated water mole-
cules is an interesting property of this complex from the per-
spective of CEST applications. Indeed, the net magnetization
of water protons (Mz/M0) at steady-state conditions and com-
plete saturation of the pool of exchangeable protons is given
by eqn (4), where c is the concentration of the probe, q is the
number of exchangeable protons, kex is the exchange rate of
exchangeable protons and T1 is the longitudinal relaxation
time of the bulk water signal. This simplified expression
shows that Mz/M0 is reduced, and thus the CEST effect is
enhanced, if T1 is long. Given the ability of paramagnetic Ln
3+
ions to shorten the relaxation times of bulk water through
chemical exchange,57 the properties of EuL as a CEST agent
are expected to be improved in the absence of water molecules







The Z-spectra of EuL were recorded at 25 and 37 °C and a
magnetic field of 7 T (Fig. 4). Already at the chelate concen-
tration of 5 mM and low saturation pulse power (5 μT), the
advantageous CEST properties of this complex became
obvious. Namely, two paramagnetically shifted and well
resolved resonances at 15 and 9.5 ppm from bulk water exhibi-
ted CEST effect of ∼25% at 25 °C, which corresponds to a
proton transfer enhancement (PTE) of 5550.61 Upon heating to
37 °C, the intensity of CEST effect remained similar, while the
shift of the resonances decreased by ∼1 ppm along with a
broadening of the peak closer to bulk water, suggesting an
increase in the exchange rates due to higher temperature. For
comparison, we recorded the Z-spectra of iopamidol (Isovue™
or Solutrast™) under the same conditions (5 mM, pH 7.4, 25
and 37 °C).
In addition to the existence of diamagnetic CEST peaks
closer to the resonance of bulk water, their intensity was
weaker than in EuL, reaching a maximum CEST effect of 20%
(Fig. 4). We have applied quantitative CEST (qCEST) analysis to
determine exchange rate values (kex),
47 using the Bloch–
McConnell (BM) equations and assuming a 3-pool model (bulk
Fig. 4 Z-spectra of EuL (lines) and iopamidol (dashes) at 25 °C (blue)
and 37 °C (red) at 5 mM concentration, B1 = 5 μT and saturation time 5 s
(PBS, pH 7.4).
Fig. 3 UV-Vis absorption (dashed green line), excitation (solid blue line)
and emission (solid red line) spectra of EuL recorded in water (10−5 M).
λexc = 268 nm, λem = 613 nm.
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water and two paramagnetically-shifted exchanging pools).
The qCEST procedure employing data of 7 different saturation
powers resulted in kex values of 1029 ± 63 Hz and 1914 ± 78 Hz
for 25 °C and 2652 ± 132 Hz and 4699 ± 229 Hz at 37 °C, with
the strongly shifted peak (14–15 ppm) having an exchange rate
which was roughly twice as slow as that of the peak with
smaller paramagnetic shift. These kex values are just slightly
higher than those reported for iopamidol also at the physio-
logical pH and fall into the optimal region for reaching the
maximal α value at the low B1 fields applied for preclinical and
clinical use (see below and description of CEST experiments in
Experimental section);62,63 hence, we proceeded with the
characterization of the EuL complex as a potential pH-sensitive
paraCEST agent. Namely, the exchange rates are expected to
change significantly with variations in pH, which would give
rise to different CEST effects. We therefore recorded a series of
Z-spectra at variable pH values from 6.0 to 8.0, using pulses
with different saturation powers ranging from 1 to 15 μT (ESI
Fig. S8†); subsequently, we performed the qCEST as well as the
inverse difference of opposite frequencies (asymmetry analysis)
to obtain the kex values and the inverse MT ratio difference
(MTRind), respectively.
46
The multi-B1 experiments at variable pH values revealed
advantageous exchange properties of EuL for pH sensing. The
exchange rates remained roughly in 2 : 1 ratio throughout the
studies for the peak with smaller shift (Table 1). CEST effects
of at least 5% were recorded already using B1 = 2.5 μT at all pH
values above 6.4; we note that this lies within the saturation
power limits permitted for use at clinical settings, ensuring
low SAR levels. Moreover, the increase of exchange rates along
with the increase in pH additionally affected the CEST effects.
When MTRind were plotted as a function of pH, the CEST
signals exhibited pH dependency until pH ∼ 7.4 (ESI Fig. S9†).
Above this pH the MTRind dropped, due to a decreased label-
ling efficiency at the given B1 level and the faster exchange.
The concentration independent ratio of different MTRind
was calculated either by comparing the effects at different fre-
quencies and same saturation power, or using the so-called
ratio of RF power mismatch method.15 When the obtained
ratios were plotted as a function of pH, the pH-dependent
effect became even more obvious (Fig. 5 and ESI Fig. S10†).
The ratio of MTRind at B1 = 7.5 μT and 2.5 μT at either frequen-
cies exhibited significant changes in the region from slightly
acidic to physiological pH (6.4–7.4, Fig. 5a), as previously
observed in the analysis and behaviour of iobitrol.15 Similar
results were obtained when the ratio of MTRind at B1 = 7.5 μT
and 14 ppm versus the signal ratio at B1 = 2.5 μT and 8.5 ppm
was calculated, or when just the ratios of the signals of two
peaks at B1 = 5 μT was used (Fig. 5b), as previously demon-
strated for the behaviour of iopamidol.64 We stress these are
very advantageous properties, highly desirable in the appli-
cation of responsive probes: all results reported here were
achieved with EuL at low saturation powers and probe concen-
trations. Next, the ratiometric analysis yields results that are
independent of probe concentration.12 Finally, the existence of
CEST effects at two frequencies that – for a fixed power –
changes proportionally with pH due to a virtually constant
ratio of kex values (Table 1 and ESI Fig. S11†) allows for a sim-
plified analysis in which the results obtained with one experi-
ment can be cross-checked with those at the other frequency,
i.e. one CEST signal can serve as an internal reference to
another one.
CEST simulations and comparisons. The above mentioned
NMR experiments performed with EuL indicated its favourable
CEST properties, especially in terms of the exchange rates being
in the optimal range, also due to the possession of two active
CEST pools. We therefore desired to compare its properties with
other reported paraCEST probes that gained significant atten-
tion. Nevertheless, direct comparison of a specific property such
as kex or the resonance frequency of the paraCEST agent is inap-
propriate as only the collective effect of several parameters
results in the finally observed CEST features.
Thus, we attempted to combine the ample knowledge and
experience collected in the field of CEST MRI in order to
foresee the paraCEST agents that comprise the most promising
properties and suggest the best direction for their further
improvement. We summarized the majority of existing
paraCEST agents by grouping them into the four groups (A to
D, respectively), according to the similarities either by the
Fig. 5 Ratio of MTRind for EuL (5 mM in PBS, 37 °C) at varying pH
values. (a) Ratio of signals at 7.5 μT and 2.5 μT at 8.5 ppm (red) and
14 ppm (blue). (b) Ratio of signal obtained with 7.5 μT at 14 ppm with the
signal obtained with 2.5 μT at 8.5 ppm; inset: the ratio of signals at 14
and 8.5 ppm and B1 = 5 μT. The pH region 6.4–7.4 is highlighted with
yellow color.
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exchange rate or paramagnetic shift (ESI Table S4†). We then
performed the initial set of simulations to emphasize the
importance of a particular physical parameter in correlation
with other standard parameters and values. Finally, we com-
bined the particular set of physical values valid for each one of
the groups and made their direct comparison. In all cases, we
considered two types of outputs, i.e. parameters that suit clini-
cal or preclinical conditions and measurements.
For paraCEST probes, we used the following grouping prin-
ciples (definitions of slow, intermediate and fast exchange
rates were simplified for the purpose of presenting these
results; otherwise they depend on the NMR time scale of the
applied magnetic field):
– Group A: Paramagnetic transition-metal complexes (Fe2+,
Ni2+, Co2+), having slow exchange rates (kex = 200–400 Hz),
high paramagnetic shift (>50 ppm) and high number of
exchanging amide protons (up to 4);17,18,65–67
– Group B: Paramagnetic EuL complex from this work,
characterized by intermediate exchange rates (kex = 1.3–2.6 kHz
at pH 7.2), fairly small paramagnetic shift (8–15 ppm) and
high number of exchanging amide protons (4);
– Group C: Paramagnetic Tm3+ complex characterized with
an intermediate exchange rate (kex = 3 kHz), high paramagnetic
shift (∼−50 ppm) and high number of exchanging amide
protons (4).21 Here, we considered also the Yb3+ complex,
which is also based on a DOTA chelator and should have
similar CEST properties. This complex exhibits smaller para-
magnetic shift (similar to that of group B); however, we esti-
mate its performance to belong to this group according to the
kex values reported for 25 °C only.
68
– Group D: Paramagnetic Eu3+ and Tb3+ complexes charac-
terized with fast exchange rates (kex = 10 kHz and above), high
paramagnetic shift (∼50 and −550 ppm) and low number of
exchanging water protons (2).20,69,70 The term fast exchange
should not be related to the actual exchange regime on the
NMR time scale, but rather how the exchange rate compared
with those of groups A–C.
For the simulations, we used the computational method
that incorporates in vivo-like water and semi-solid MT pro-
perties.71 Namely, by defining a set of different parameters for
the abstract cases or existing paraCEST probes, we estimated
CEST effects,72 which can be expected in the brain tissue (grey
matter) at 7 T magnetic field. Also, we assumed the use of a
pulse with lower SAR (B1 = 5 μT, saturation time = 0.5 s) to
mimic the clinical CEST MRI limits, whereas the pulses with
higher power and longer duration and thus higher SAR can be
tolerated for the preclinical cases without having significant
impact for welfare of the animal subject (B1 = 10 μT, saturation
time = 5 s). These two conditions are important restrictions, if
performance is compared without restriction for SAR, faster
exchanging sites will always win. All these studies assumed
cases with same concentration of the exchanging protons
(10 mM); otherwise, the obtained results can be scaled by the
appropriate factor, if lower or higher concentrations are used.
We first performed calculations for the abstract cases, aiming
to show variations of the particular physical parameter while
varying only one of these parameters (Fig. 6). If fixing the
exchange rate to 200, 2000 and 10 000 Hz (slow to fast
exchange rates), respectively, the results indicate that probes
with the intermediate kex (up to a few kHz, see below) are the
most suitable for the clinical settings, irrespective of the fre-
quency shift of the CEST resonance (Fig. 6a). On the other
hand, generally faster exchange rates are preferred for the pre-
clinical settings, while the frequency shift of the paraCEST
agent shows the following trend: a shift of at least 50 ppm is
preferred, whereas at >100 pm the negative effect of the semi-
solid MT is completely eliminated (Fig. 6b). We note that
larger paramagnetic shifts are preferred at scanners with the
lower magnetic field (e.g. at 3 T) to reach beyond the semi-
solid MT, while this effect is reducing with the increase of the
magnetic fields (i.e. semi-solid MT covers smaller frequency
region at higher magnetic fields; hence lower paramagnetic
shifts of the CEST effect on the paraCEST agent can be
tolerated).73
Next, we checked the optimal B1 fields (saturation powers)
for the maximal labelling efficiency for these three types of
exchange rates (slow, intermediate and fast), at the fixed reso-
nance frequency that corresponds to EuL (δB = 15 ppm). At
both the clinical and preclinical settings, intermediate
exchange rate (groups B–C) has the maximal α in suitable
regions of B1 that match the requirements (B1 < 5 or 10 μT,
respectively). For groups A and D (low and high kex, respect-
ively) it is obvious that labelling exists; however, it is less
efficient (Fig. 6c and d).
Finally, when the value for CEST resonance frequency is
fixed against the variable kex values, one concludes that an
intermediate exchange rate of just a few kHz is optimal for the
best labelling; furthermore, the large paramagnetic shift of the
CEST resonance(s) is advantageous, although the differences
are not significant at the clinical settings (Fig. 6e). However,
highly shifted CEST resonances are very advantageous for pre-
clinical conditions (Fig. 6f).
Another set of simulations was performed using the
specific set of parameters valid for each of the A–D groups of
molecules (ESI Table S4†). The most important matter in these
calculations was including the difference in the abundance of
exchanging protons that cause CEST effect. Namely, the calcu-
lations assumed same concentrations of molecules (5 mM), in
which the clear advantage went in direction of those having
higher number of exchanging protons per molecule (groups A–
C).
Furthermore, we included two examples for each group A
and D, aiming to provide better comparison between structu-
rally and behaviourally different systems. In specific, we
included a macrocyclic Fe2+ complex,65 an acyclic Co2+
complex,18 macrocyclic Eu3+ and Tb3+ complexes20,69,70 as
group A1, A2, D1 and D2 probes, respectively (ESI Table S4†). In
this calculation, we did not consider faster T1 relaxation
noticed for the group A and C probes; this effect will reduce
the maximal CEST effects that is based on their other physical
properties presented here (kex, paramagnetic shift, number of
exchanging protons).
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The obtained results were expressed either in the form of
simulated Z-spectra (Fig. 7a and b) or CEST effects (Fig. 7c
and d), again for clinical and preclinical settings (Fig. 7a, c
and b, d, respectively). They again showed the advantageous
properties of the paramagnetic EuL platform.74 Although the
other three groups of probes possess CEST effects that are
well paramagnetically shifted, their other features result in
similar magnitude of the signal as EuL. Indeed, EuL has
excellent properties for the clinical settings: it is not only that
its effects are comparable to those of group A and C probes –
indeed, only EuL together with group A2 probe exhibit two
strong CEST signals (Fig. 7c) suitable for ratiometric investi-
gations. Also, while other compounds show increased CEST
effects for preclinical settings, EuL shows almost the same
effect size in both settings.
The results presented here show some further aspects that
should be considered in future design and application of
paraCEST probes. Group A2 and C probes also display strong
signals at both clinical/preclinical settings, mainly due to pos-
session of high number of exchanging protons, optimal or
slightly slower exchange rates and high paramagnetic shift
(Fig. 7d). Finally, the group D probes show limitations for
further applications under clinical settings. Here, lower
number of exchanging protons clearly has a major impact on
the final CEST effect, while fairly fast exchange rates make
them suitable for possible investigations at preclinical settings
(Fig. 7d and ESI Fig. S12†).
MRI experiments. Following the theoretical calculations to
highlight the MRI potential of EuL, an additional set of
measurements was performed on tube phantoms in the MRI
scanner to validate the probe experimentally. Six tubes with
identical concentrations of EuL (3 mM) were prepared in PBS
at different pH (6.0, 6.4, 6.8, 7.2, 7.6 and 8.0). The images were
recorded at room temperature and varying saturation powers
(3.0, 4.0, 5.0, 6.0 and 7.5 μT). The lower temperature and
hence the exchange rates reflected on the lower intensity of
CEST effect. Nevertheless, the obtained signals were analysed
in the same fashion as the former NMR experiments at 37 °C
(ESI Fig. S13†). Consequently, the MTRind ratio of different fre-
quencies and saturation powers could be used to obtain a set
of pH maps (Fig. 8 and ESI Fig. S14 and 15†).15 Due to low kex
and therefore low MTRind intensity at only 3 mM EuL, the MRI
contrast at pH 6.0 was insufficient to extract the correct pH
value (Fig. 8); such signals can in principle even be filtered by
a pixelwise threshold for the MT. However, the pH region typi-
cally detected in solid tumours (6.5–7.0)75 or ischemia76 was
well covered and reliably determined by the MRI phantom
experiment with EuL.
Fig. 6 Simulated CEST effects of paraCEST probes at 7 T magnetic field at (a, c and e) clinical (B1 = 5 μT, sat. time = 0.5 s) and (b, d and f) preclinical
settings (B1 = 10 μT, sat. time = 5 s), respectively. (a and b) Dependence at three different kex regimes as a function of paramagnetic shift of CEST
resonance. (c and d) Dependence at three different kex regimes as a function applied saturation power at δ = 15 ppm. (e and f) Dependence at three
different resonance shifts as a function of kex value.
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In summary, we have reported on a paramagnetic platform
that forms kinetically highly inert complexes and has an excellent
outlook for the development of entirely new class of paraCEST
probes. The investigated Eu3+ chelate displays very affirmative
CEST features due to two paramagnetically shifted protons that
are in slow to intermediate exchange with bulk water. The vari-
ations in pH reflect on the intensity of the obtained CEST effect,
which exhibits pH-dependent behaviour either at a single reso-
nance or from the ratio of applied saturation powers and
different resonance peaks. Moreover, the high intensity of the
CEST effect allows for applications of small quantities of this
paraCEST probe, as well as low saturation powers that match
clinically approved protocols. Indeed, the theoretical calculations
predict that this platform has one of the best set of cumulative
properties for CEST applications, which should become the land-
mark for development of novel classes of paraCEST probes.
We want to highlight that this promising platform likely
requires additional chemical modifications to be used for
in vivo applications. For instance, it has been shown that tri-
cationic DOTA-tetraamide complexes are toxic, while negatively
charged analogues are well tolerated at much higher doses.77
Nevertheless, the chemical nature of this platform envisions
an immense number of potential chemical transformations
and the development of a great variety of structures that, com-
bined with a number of chelated paramagnetic metals, can
further improve on the already excellent features to result in
probes sensitive to different types of targets. For instance,
functionalization of the acetamide pendants with negatively
charged groups at the α-carbon would result in negatively
charged complexes that should maintain the D2 symmetry of
the complex and two resonances for the amide groups.
Ultimately, this macrocyclic platform could pave the way to
many exciting advances in the field of responsive paraCEST
agents with high potential for clinical applications.
Fig. 7 Simulated (a and b) z-spectra and (c and d) CEST effects of selected paraCEST probes at 7 T magnetic field at a, (c) clinical (B1 = 5 μT, sat.
time = 0.5 s) and (b and d) preclinical settings (B1 = 10 μT, sat. time = 5 s), respectively. Water and semisolid MT parameters were chosen to mimic
grey brain matter, in specific: water relaxation times, T1w = 1.67 s and T2w = 0.043 s; fractional concentration, transverse relaxation time, exchange
rate and chemical shift of the MT pool: χMT = 0.05, T2MT = 9.1 µs, kex(MT) = 40 Hz, δMT = 0 ppm; Super-Lorentzian lineshape.
74
Fig. 8 CEST MRI on tube phantoms with EuL (3 mM in PBS, RT). pH
maps were generated from the ratio of experiments done at B1 = 7.5 and
4 μT, saturation time 5 s and with the peak at 9.7 ppm.
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